7663 (Aromasin 25 mg)
Generic Name: exemestane
Pill imprint 7663 has been identified as Aromasin 25 mg.
Aromasin is used in the treatment of breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Aromasin 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 25 mg
- Prescription only
- Drug Class:
- Aromatase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- Inactive Ingredients:
polyethylene glycol 6000
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|54868-5261||Physicians Total Care Inc (repackager)|
|49999-0986||Lake Erie Medical and Surgical Supply (repackager)|
More about Aromasin (exemestane)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 12 Reviews – Add your own review/rating
- Generic Availability
- Drug class: aromatase inhibitors
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.